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Abstract
Based on previous data on the histamine radioprotective effect on highly radiosensitive tissues, in the present work
we aimed at investigating the radioprotective potential of the H4R ligand, JNJ7777120, on ionizing radiation-induced
injury and genotoxic damage in small intestine, salivary glands and hematopoietic tissue. For that purpose, rats were
divided into 4 groups. JNJ7777120 and JNJ7777120-irradiated groups received a daily subcutaneous JNJ7777120
injection (10 mg/kg) starting 24 h before irradiation. Irradiated groups received a single dose of 5 Gy on whole-body
using Cesium-137 source and were sacrificed 3 or 30 days after irradiation. Tissues were removed, fixed, stained
with hematoxylin and eosin or PAS staining and histological characteristics were evaluated. Proliferative and
apoptotic markers were studied by immunohistochemistry, while micronucleus assay was performed to evaluate DNA
damage. Submandibular gland (SMG) function was evaluated by methacholine-induced salivation. Results indicate
that JNJ7777120 treatment diminished mucosal atrophy and preserved villi and the number of crypts after radiation
exposure (240±8 vs. 165±10, P<0.01). This effect was associated to a reduced apoptosis and DNA damage in
intestinal crypts. JNJ7777120 reduced radiation-induced aplasia, preserving medullar components and reducing
formation of micronucleus and also it accelerated bone marrow repopulation. Furthermore, it reduced micronucleus
frequency in peripheral blood (27±8 vs. 149±22, in 1,000 erythrocytes, P<0.01). JNJ7777120 completely reversed
radiation-induced reduced salivation, conserving glandular mass with normal histological appearance and reducing
apoptosis and atrophy of SMG. JNJ7777120 exhibits radioprotective effects against radiation-induced cytotoxic and
genotoxic damages in small intestine, SMG and hematopoietic tissues and, thus, could be of clinical value for
patients undergoing radiotherapy.
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Introduction
Effective radiotherapy to treat cancer patients should include
maximal tumor cell killing with minimal injury to normal tissue.
A cautious balance between the total dose of radiation
delivered and the threshold limit of the surrounding normal
critical tissues is essential to optimize outcomes. The
prevention or treatment of early and late radiotherapy effects
would improve quality of life and increase cancer curability by
intensifying therapies. In this sense, the role of radioprotective
compounds is of utmost importance in clinical radiotherapy
[1,2]
Several compounds have been reported to offer potential for
radiation protection, but most of them are not suitable for
clinical application due to toxicity and poor specificity [1–3].
Ionizing radiation-induced free radicals and reactive oxygen
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species (ROS) damage vital cellular targets such as DNA and
membranes, which could lead to cell death and functional
failure of irradiation-sensitive tissues such as gastrointestinal
epithelium and hematopoietic system, in which the response is
determined by a hierarchical cell lineage, composed of stem
cells and their differentiating offspring [1,2].
Bone marrow is the primary hematopoietic tissue in
mammals producing all blood cells and whole-body irradiation
reduced bone marrow cellularity and blood cell count [1,4].
Within the digestive system small intestine and salivary glands
are highly radiosensitive [1]. Side effects of pelvic or abdominal
radiation therapy include nausea, diarrhea, and villous atrophy
while radiation-induced xerostomia still represents a common
adverse effect after radiotherapy for head-and-neck
malignancies [1–3].
In this regard, it was previously reported that histamine
significantly protects in mice and rats two of the most
radiosensitive tissues, small intestine and bone marrow, from
high doses of gamma radiation [5–7]. In agreement with these
data, histamine prevents functional and histological alterations
of salivary glands produced by ionizing radiation [3]. In
addition, histamine has the ability to enhance the radiosentivity
of breast malignant cells [8].
Histamine [2-(4-imidazolyl)-ethylamine] is an endogenous
biogenic amine and is known since long to be a pleiotropic
mediator in different (patho) physiological conditions, which
exerts its actions through the interaction with four histamine
receptor subtypes [9]. The discovery of the human histamine
H4 receptor (H4R) has revealed novel functions for histamine
and opening new perspectives in histamine pharmacology
research. H4R appeared to have a selective expression pattern
restricted to medullary and peripheral hematopoietic cells and it
is assumed to play an important pro-inflammatory role in
various diseases, including bronchial asthma, atopic dermatitis,
and pruritus. In addition, H4R was reported to be present on
other cell types including intestinal epithelium, spleen, lung,
stomach, central nervous system, salivary glands and cancer
cells [9–11]. Over the past decade, the indole derivative
JNJ7777120 (Table 1), developed by Johnson and Johnson
Pharmaceuticals, has more than a thousand-fold selective over
other histamine receptor subtypes and has become the
reference H4R antagonist, being extensively used to assess the
H4R pathophysiological role [10,12,13].
Based on previous data on the histamine radioprotective
effect on highly radiosensitive tissues, in the present work we
aimed to investigate the radioprotective potential of the H4R
ligand, JNJ7777120, evaluating its effect on reducing ionizing
radiation-induced injury and genotoxic damage in the rat small
intestine, salivary glands and hematopoietic tissue.
Materials and Methods
Treatment and irradiation
Eighty 10-week-old male Sprague-Dawley rats, weighing
200-230 g were purchased from the Division of Laboratory
Animal Production, School of Veterinary Sciences, University of
La Plata, Buenos Aires and were randomly separated into 4
groups (n = 20 each). Rats were maintained in our animal
health care facility at 22 to 24°C and 50% to 60% humidity on a
12 h light/dark cycle with food and water available ad libitum.
To determine the potential radioprotective effect of
JNJ7777120 (Table 1) on small intestine, SMG and bone
marrow we used the same experimental procedures that were
previously described in detail [3,5–7]. Briefly, JNJ7777120 and
JNJ7777120-5Gy groups received a daily subcutaneous
JNJ7777120 injection (10 mg/kg) starting 24 h before
irradiation and which continued until 3 days post-irradiation
while untreated groups received saline. Irradiated groups
received a single dose of 5 Gy on whole-body using
Cesium-137 source and animals were sacrificed 3 or 30 days
after irradiation.
Three days post-irradiation methacholine-induced salivary
secretion was measured (n = 4 each group) or animals were
anesthetized by CO2 inhalation and then immediately sacrificed
by cervical dislocation and SMG, small intestine and femur
bone marrow were removed, weighed, and histological and
histochemical characteristics were evaluated (n = 6 each
group). Additionally, 30 days post-irradiation other group of
animals (n = 6 each group) were sacrificed to evaluate
histological parameters. For oxidative damage evaluation 3
days post-irradiation additional animals were employed (n = 4
each group).
Animal procedures were in accordance with
recommendations from the Guide for the Care and Use of
Laboratory Animals of the National Research Council, USA,
1996, 2011, and protocols were approved by the Ethical and
Educational Committee for the Use and Care of Laboratory
Animals of the School of Pharmacy and Biochemistry.
Histopathological studies
SMG and small intestine were removed and were fixed with
10% neutral buffered formalin while femur bone marrows were
fixed with Bouin’s solution. Tissue samples were embedded in
paraffin and cut into serial sections of 4 µm thick. The
histopathological characteristics were examined on tissue
sections after hematoxylin-eosin (H&E) staining as it was
previously described [3,6,7]. Also, specimens were stained with
periodic acid schiff (PAS) staining and counterstained with
hematoxylin to evaluate glycogen deposits.
Table 1. Molecular characteristics of JNJ7777120.
IUPAC 1-[(5-Chloro-1H-indol-2-yl)carbonyl-]-4-methylpiperazine
Molecular Weight 277.76
Source Johnson & Johnson Pharmaceutical Research and Development, San Diego, CA
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Immunohistochemical staining
Immunohistochemistry was performed as it was previously
described [3,6,7]. Briefly, after blocking tissues were incubated
with primary mouse anti-proliferating cell nuclear antigen
(PCNA, 1:100, Dako Cytomation, Glostrup, Denmark), rabbit
anti-aquaporin 5 (AQP5, 1:50, Abcam, Cambridge, MA, USA)
or rabbit anti-H4R (1:100) (Alpha Diagnostic International, San
Antonio, TX, USA), antibodies overnight in a humidified
chamber at 4°C. Immunoreactivity was detected by using
horseradish peroxidase-conjugated anti-mouse or anti-rabbit
antibodies and visualized by diamino-benzidine staining (Sigma
Chemical Co., St. Louis, MO, USA). Specimens were
counterstained with hematoxylin.
Apoptotic cells were detected, as earlier reported [3,5,7],
using ApoptagTM plus peroxidase in situ apoptosis Detection Kit
(CHEMICON International, Temecula, CA, USA) according to
the manufacturer’s instructions.
Light microscopy was performed on an Axiolab Karl Zeiss
microscope (Göttingen, Germany). All photographs were taken
using a Canon PowerShot G5 camera (Tokyo, Japan).
Micronucleus assay
A micronucleus test performed in polychromatic erythrocytes
of bone marrow was carried out according to Schmid [14] and
also in peripheral blood, with minor modifications [15]. Bone
marrow smears were prepared from rat femurs while peripheral
blood samples were obtained from the caudal vein of the same
adults specimens. At least 1,000 cells per rat were counted,
and the data were obtained from 6 rats. Micronucleus
evaluation in small intestine was performed according to
Vanhauwaert et al. [16] with adaptation as it was previously
described [7]. The criteria of the micronucleus in bone marrow
follow Schmid [14]: i) the same staining as the main nucleus; ii)
smaller than 1/3 diameter of the main nucleus; iii) not attached
to the main nucleus. Cells were visualized and micronuclei
were counted under Axiolab Karl Zeiss microscope (Göttingen,
Germany).
Salivary secretion
Salivation was assessed in anesthetized rats (chloralose 100
mg/kg, 0.5 ml NaCl-0.9%) (FLUKA, Berlin, Germany) as it was
previously described [3]. Briefly, the right femoral vein was
cannulated to administer the sialagogic agonist, methacholine
(FLUKA) at different concentrations (0.3, 1, 3, 10 and 30 µg/kg,
in saline). No basal salivation was observed from the glands.
Salivary samples were collected and the quantity of saliva was
determined by weighing. Results were expressed as mg of
saliva per gland.
Evaluation of total thiols, TBARS levels and catalase
activity
The thiobarbituric acid reactive species (TBARS) assay is a
well-established method for screening and monitoring lipid
peroxidation. The method used in the present study, was
previously described by Yagi [17]. Briefly, a portion of tissue
was homogenized in phosphate buffer pH 7.4, and was
transferred to a tube containing trichloroacetic acid, HCl and 2-
thiobarbituric acid. The mixture was boiled for 1 h and then
centrifuged at 3,000 rpm for 20 min at 4°C. The absorbance in
the resulting pink-stained TBARS supernatants was
determined in a spectrophotometer (Genesys 10 UV, Thermo
Scientific) at 535 nm. The acid did not produce color when
tested without the addition of the sample. A molar extinction
coefficient of ε = 1.56 x 105 M-1 cm-1was used for calculations.
Tissue total thiols concentration was estimated by the ability
of the sulfhydryl group to reduce 5,5´-dithiobis(2-nitro-benzoic
acid) (DTNB, Sigma-Aldrich, St. Louis, Mo, USA) according to
Tietze [18]. Briefly, 35 mg of tissue were homogenized with ice-
cold HClO4 (0.5 N) and centrifuged for 10 min at 600g. The pH
of the supernatant was neutralized with Na 3PO4. 20 µl of the
supernatant were mixed with 50 µl of freshly prepared DTNB
solution (6 mM) in 1 ml of 100 mM phosphate buffer and the
mixture was incubated for 1 min to form a yellow-colored
anionic product whose absorbance is measured at 412 nm
against a reagent blank. A molar extinction coefficient of ε =
13.6mM-1 cm-1was used for calculations.
Catalase activity was measured spectrophotometrically by
monitoring the disappearance of H2O2 at 240 nm, as it was
previously described [8]. A unit of catalase was defined as the
disappearance of 1 µmol of H2O2/min (ε 43.6 M-1cm-1).
Cell culture and radiation dose–response curves
The human breast cancer cell lines MDA-MB-231 and
MCF-7 (American Type Tissue Culture Collection, VA, USA)
were cultured in supplemented RPMI 1640 as it was previously
described [8]. For the radiosensitivity studies, MCF-7 and
MDA-MB-231 cells were seeded in 6-well plates (1,200 cells/
well) and were treated with 10 µM JNJ7777120 or remained
untreated. The radiobiological parameters (SF 2Gy: fraction of
surviving cells after exposure to 2 Gy dose; Dose 0.01: dose
that reduces survival to 1%; Dose 0.10: dose that reduces
survival to 10%) were calculated from the clonogenic surviving
curves as it was described [8].
Statistical analysis
Data shown are mean ± standard error of the mean (SEM) of
at least two independent experiment. Statistical evaluations
were made by analysis of variance (ANOVA) that was followed
by Newman-Keuls’ Multiple Comparison Test, using GraphPad
Prism Version 5.00 software (San Diego, CA, USA). P values <
0.05 were considered significant.
Results
Radioprotective effect of JNJ7777120 on small intestine
We first evaluated the effect of JNJ7777120 in radiation-
induced damage on small intestine. JNJ7777120 preserved
histopathological characteristics of rat small intestine 3 days
post-irradiation. JNJ7777120 diminished mucosal atrophy,
disruption of muscular layer fibers, villous edema and
preserved the number of crypts after radiation exposure (240±8
vs. 165±10, P<0.05). In addition to the preservation of mucosal
trophism, JNJ7777120 also restored the radiation-induced
Radioprotective Potential of JNJ7777120
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reduction in goblet cells in crypts evaluated with PAS staining
and prevented severe serous edema (Figure 1).
Furthermore, at 3 days post-irradiation a significant increase
in pyknotic nuclei corresponding to apoptotic cells in crypt was
observed, effect that was completely blocked by JNJ7777120
treatment. On the other hand, the marker of proliferation PCNA
was high in both untreated and JNJ7777120-treated rats
(Figure 1).
Micronuclei assay was investigated as a biomarker for
evaluating ionizing radiation-induced chromosomal damage.
The number of micronuclei in intestinal cells was significantly
increased after irradiation, and JNJ7777120 treatment
normalized it (0.5±0.2 vs. 4.5±0.2, P<0.05) (Figure 1).
Histopathological changes of small intestine were associated
with an increase in TBARS and a decrease in total cellular
thiols, while no significant changes of catalase activity was
observed (Table 2). Significant improvement of TBARS and
thiol levels was observed after JNJ7777120 treatment (Table
2).
Effect of JNJ7777120 on SMG of irradiated animals
We further investigated the effect of JNJ7777120 in
radiation-induced functional and morphological alterations of
SMG. SMG function was evaluated by determining the
salivation after methacholine stimulation in treated and
untreated animals. Radiation significantly reduced salivary
secretion by approximately 35-50% at 10 and 30 µg/Kg
methacholine concentration in comparison to untreated rats
while decreased SMG wet weight relative to body weight
(Figure 2 A & B). On the other hand, JNJ7777120 treatment
completely blocked radiation-induced reduced salivation at all
concentration of methacholine used and this was associated
with a conservation of SMG wet weight (Figure 2 A & B).
Histopathological analysis demonstrated that radiation
produced severe gland atrophy with alteration in the epithelial
architecture, partial loss of eosinophilic secretor granular
material, increased acinar vacuolization and mild edema.
JNJ7777120 treatment completely prevented histological
damage of SMG, which showed normal histological features
(Figure 3 A).
It is important to note that in non-irradiated rats, non-
significant effects were produced by JNJ7777120 in functional
or morphological characteristics of SMG (Figures 2 & 3).
In addition, results show that the water channel protein
aquaporin-5 (AQP5) was localized mainly in the apical
membranes of acinar cells of non-irradiated SMG, and
treatment with JNJ7777120 did not affect AQP5 distribution.
Radiation diminished AQP5 immunoreactivity and altered its
localization, which was observed at the apical, basolateral, and
basal plasma membrane. JNJ7777120 seemed to preserve
AQP5 immunoreactivity and distribution in irradiated SMG
(Figure 2 D).
Furthermore, it has been suggested that the radiation-
induced imbalance between apoptosis and proliferation in SMG
is responsible for the impairment of salivary gland function that
leads to a decreased salivation [3]. Therefore, the
JNJ7777120-mediated modulation of proliferation (PCNA) and
apoptosis (TUNEL) markers were also evaluated by
immunohistochemical analysis.
Figure 3 shows a very low PCNA expression and a small
number of TUNEL-positive cells, which were not modified by
JNJ7777120 treatment in non-irradiated rats. Irradiation
markedly reduced PCNA immunoreactivity while significantly
increased apoptotic cells in all gland compartments including
acinar cells, granular convoluted cells, intercalated ductal cells
and excretory ducts. In contrast, JNJ7777120 administration
produced a partial preservation of PCNA-positive cells while
reduced the number of apoptotic cells in the SMG of irradiated
animals (59.1±2.9 vs. 103.4±5.6, P<0.001).
In addition, the immunohistochemical analysis of H4R
showed that it was detected in some acini and also ducts of rat
SMG (Figure 2 C).
Thiol levels were decreased and catalase activity was
increased, while TBARS levels were not modified upon
radiation exposure and JNJ7777120 administration was unable
to modify these parameters (Table 2).
Effect of JNJ7777120 on hematopoietic tissue of
irradiated animals
Pathological examinations of bone marrow 3 days after total
body irradiation show that JNJ7777120 administration
efficiently ameliorated the radiation-induced reduction of bone
marrow cells (aplasia) (Figure 4 A). This effect was correlated
with a decrease in the radiation-induced enhanced micronuclei
production in bone marrow cells (Figure 4B). In agreement with
these results, JNJ7777120 treatment reduced micronuclei
frequency in peripheral blood (27±8 vs. 149±22, MN/1,000
erythrocytes, P<0.05) (Figure 4 B).
Accordingly, JNJ7777120 enhanced bone marrow
repopulation after 30 days of radiation exposure. JNJ7777120
almost completely conserved the medullar progenies,
preserving myeloid, erythroid, lymphoid and megakaryocytic
precursors while diminished the adipose replacement
compared to bone marrow derived from untreated and
irradiated rat group (Figure 5). In addition, similar PCNA
immunoreactivity was observed in bone marrow from the
different experimental groups (Figure 5).
Furthermore, radiation reduced the number of germinal
centers, considerably decreased cellularity of
immunocompetent cells, and enhanced vascular damage with
focal hemorrhage in spleen. JNJ7777120 treatment
significantly preserved spleen cellularity and germinal centers
to almost normal extent (Figure 4 C). The preservation of
spleen histology produced by JNJ7777120 was associated with
a conservation of spleen wet weight, which was reduced after
radiation exposure (Figure 4 D). Also, a significant increase in
TBARS levels was observed after radiation exposure, while
JNJ7777120 treatment completely reversed this effect and
increased catalase activity in spleen. Total thiols were not
significantly modified in irradiated and non-irradiated, treated or
untreated spleen (Table 2).
Radioprotective Potential of JNJ7777120
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Figure 1.  Effect of JNJ7777120 on radiation-induced cytotoxic and genotoxic damage of rat small intestine.  (A)
Representative pictures of (a,e) Normal histological appearance of untreated and (b,f) JNJ7777120-treated small intestine. (c,g)
Intestine of irradiated rats displaying reduction in the number of crypts (arrow) with decreased goblet cells (g), villous edema (arrow
head) and severe edema in serosa ([, c). (d,h) Intestine of JNJ7777120-treated and irradiated animals showing preservation of the
mucosa, absence of vascular damage and an increased number of crypts (d) with restored presence of goblet cells (h). (a–d) H&E
staining. (e–h) PAS staining. (i) Occasional TUNEL-positive cells in crypts in untreated and (j) JNJ777120-treated rats. (k) Massive
presence of TUNEL-positive cells in crypts of irradiated rats. (l) Significant reduction of TUNEL-positive cells in crypts of treated and
irradiated rats. Arrow head indicate positive cells. (m–p) Similar PCNA immunoreactivity in crypts from all groups. Pictures were
taken at 630x-fold magnification. Scale bar= 20 µm. (B) Histopathological characteristics and average number of apoptotic cells and
micronucleus in small intestine. §The number of TUNEL positive cells per crypt are expressed as means ± SEM. <The number of
micronuclei per 100 cells are expressed as means ± SEM. *P<0.05 vs. Untreated; # P<0.05 vs. Untreated-5Gy.
doi: 10.1371/journal.pone.0069106.g001
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Effect of JNJ7777120 on the radiobiological parameters
of breast cancer cells
In order to determine the JNJ7777120 compound selective
cytoprotection of normal tissues, we also evaluated the
radiobiological response of two human breast cancer cells.
Results indicate that the radiobiological parameters of MCF-7
and MDA-MB-231 cells were not modified upon JNJ7777120
treatment (Figure 6).
Discussion
This study aims to investigate the radioprotective effect of
JNJ7777120 compound on gamma radiation-induced damage
on small intestine, SMG and hematopoietic tissue.
The microcolony assay, developed by Withers and Elkind,
measures the number of regenerating crypts per intestinal
circumference at 3-4 days after radiation, serves as a surrogate
for stem cell survival, directly quantifies radiation dose-
dependent lethality of the crypts and is a predictive measure of
gastrointestinal damage because it is not influenced by
concomitant damage to other organs such as bone marrow [1].
Table 2. Effect of JNJ7777120 on thiobarbituric acid
reactive substances (TBARS) level, total thiols content and
catalase activity in small intestine, spleen and
submandibular glands (SMG) of irradiated and non-
irradiated rats.
 Groups
 Untreated JNJ7777120 Untreated- 5GyJNJ7777120- 5Gy
Intestine     
TBARS 0.40±0.02 0.33±0.04 0.78±0.02* 0.23±0.03#
Total Thiols 4.78±0.20 6.00±0.40 3.83±0.38 4.75±0.29
Catalase
Activity 7.83±1.08 6.65±0.52 5.95±0.69 5.91±0.71
Spleen     
TBARS 0.18±0.02 0.15±0.01 0.35±0.05* 0.16±0.02#
Total Thiols 4.14±0.42 3.66±0.02 4.36±0.60 4.14±0.70
Catalase
Activity 780.00±55.80 692.30±67.30 750.30±42.20 1416.00±55.10*#
SMG     
TBARS 0.18±0.01 0.19±0.02 0.17±0.01 0.16±0.01
Total Thiols 3.76±0.31 3.04±0.20 2.36±0.11* 2.44±0.26*
Catalase
Activity 31.88±2.14 28.80±0.97 43.48±1.81* 49.46±1.91*
Ionizing radiation augmented TBARS level in the intestine and spleen compared to
untreated rats while JNJ7777120 blocked this effect. Data represent the means ±
SEM (* P<0.05 vs. Untreated; # P<0.05 vs. Untreated-5Gy). (TBARS are
expressed as nmol/mg protein.) Total thiols decreased in SMG of untreated-5Gy
and JNJ7777120-5Gy rats compared to untreated rats. Data represent the means
± SEM (* P<0.05 vs. Untreated). (total thiols are expressed as mmol/mg tissue.)
Catalase activity augmented in the spleen of JNJ7777120-5Gy rats and in the
SMG of untreated-5Gy and JNJ7777120-5Gy rats. Data represent the means ±
SEM (* P<0.05 vs. Untreated; # P<0.05 vs. Untreated-5Gy). (catalase activity is
expressed as U/mg protein.)
Whole body irradiation produced epithelial cell damage in
small intestine, which accounts for reduction of the number of
regenerating crypts, structural changes of the villi, vascular
damage and mucosal superficial ulceration as it was previously
described [7]. JNJ7777120 treatment was effective in
preventing radiation-induced damage to small intestine,
preserving mucosal epithelium, with absence of vascular
damage and an increased number of crypts that were
comparable to non-irradiated animals.
The gastrointestinal tract is covered by a lubricant mucous
layer that constitutes a protective barrier against
microorganisms, physical and chemical attacks. Mucus is
secreted by goblet cell, which arise from pluripotent stem cells
present at the base of crypt [19]. Goblet cell ablation has been
recognized as one of the most consistent hallmarks of
chemotherapy- and radiotherapy-induced intestinal damage
[20]. Irradiation decreases the number of goblet cells in crypts,
resulting in a reduction of the production of mucin while
JNJ7777120 restores the number of goblet cells. Previous
acute radiation data indicate that the response of goblet cell is
complex, decreasing in cell number at 72 h after irradiation,
while others demonstrate increases particularly after several
weeks and months [19].
Radiation induces apoptosis of radiosensitive cells in the
intestinal crypt cells, which are responsible for renovation and
maintenance of the intestinal cellular architecture [1]. The
protective effect of JNJ7777120 on small intestine was mainly
associated with a reduced apoptosis in intestinal crypts of
irradiated rats.
It is well known that the biological effects of ionizing radiation
results principally from damage to DNA and double-strand
breaks, which can lead to chromosomal aberrations and are
the most relevant lesions responsible for most biologic insults,
including cell killing [1]. The micronucleus test is a tool for
genotoxic assessment, being a reliable biomarker for
evaluating ionizing radiation-induced chromosomal damage
[7,21]. JNJ7777120 administration reverses radiation-induced
micronuclei frequency in intestinal cells, suggesting that this
compound reduced radiation-induced genotoxic damage.
Similar radioprotective effects were observed on rat and
mouse small intestine upon histamine administration (0.1
mg/kg) [5,7].
Irradiation is a central treatment modality administered for
head and neck cancers. However, a significant drawback of
radiotherapy is the severe and irreversible gland functional and
structural alterations, which result in salivary dysfunction and
consequent xerostomia [1,22]. Present findings demonstrate
that JNJ7777120 administration can significantly protect the
SMG from deleterious effects of irradiation. Histological studies
revealed radiation-induced prominent atrophy and
degeneration. JNJ7777120 completely reverses radiation-
induced reduced salivary secretion and histological alterations,
preserving SMG function. The data indicate that the
cytoprotective mechanisms of JNJ7777120 may be related to
improved cell proliferation and inhibition of cell apoptosis.
The water channel protein AQP5 is highly expressed in
salivary glands and is important for salivary secretion,
considering that knockout mice lacking AQP5 show markedly
Radioprotective Potential of JNJ7777120
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depressed rates of salivation. AQP5 is localized almost
exclusively at the apical plasma membrane of the acinar and
the intercalated duct cells in the rat SMG [23]. Ionizing radiation
significantly down-regulates AQP5 expression in the SMG,
which may contribute to radiation-induced salivary
dysfunction[24,25]. . Present results show that AQP5 is
localized in the apical membranes of acinar cells of non-
irradiated SMG, while radiation diminished AQP5
immunoreactivity and altered its localization, which was not
principally observed at the apical plasma membrane.
JNJ7777120 administration seemed to preserve AQP5
distribution, suggesting that the protection of acinar cells by
JNJ7777120 might also involve conservation of AQP5
expression with typical localization. In this sense, other
experimental radioprotective molecules reduce radiation-
induced salivary gland damage by preventing the reduction of
AQP5 expression [25].
The presence of H1R and H2R in salivary glands was
previously described [26]. In this study, we demonstrated the
expression of H4R in some acinar and excretory ductal cells by
immunohistochemistry, indicating that JNJ7777120 could be
acting on H4R expressed in SMG. In line with our results, it was
recently reported the expression of H4R in human salivary
glands. H4R level was reduced in salivary glands of patients
with Sjögren’s syndrome, which is a chronic autoimmune
disease characterized by severe alterations in both the quality
Figure 2.  Effect of JNJ7777120 on radiation-induced damage on salivary function.  (A) Mean salivary secretion in irradiated
and non-irradiated, untreated and JNJ7777120-treated rats. Error bars represent the means ± SEM (**P<0.01, ***P<0.001, vs.
Untreated, ###P<0.001 vs. Untreated-5Gy). (B) ¶SMG’s percentage of body weight (SMG weights were divided by total body weight
in grams and multiplied by 100). Data represent the means ± SEM (*P<0.05 vs. Untreated; #P<0.05 vs. Untreated-5Gy). Inset:
JNJ7777120 compound significantly preserves SMG mass. (C) H4R immunoreactivity. H4R was detected in some (a) acini and also
(b) excretory ducts. (D) AQP5 immunoreactivity. AQP5 was detected almost exclusively in acini in (a) untreated, (b) JNJ777120-
treated and (d) treated and irradiated rats. (c) Reduce AQP5 immunoreactivity and altered distribution in SMG of irradiated rats.
Pictures were taken at 630x-fold magnification. Scale bar= 20 µm.
doi: 10.1371/journal.pone.0069106.g002
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Figure 3.  Effect of JNJ7777120 on radiation-induced morphological, proliferative and apoptotic alterations in the rat
SMG.  (A) SMG histopathology. (a,e) Normal histological appearance of untreated and (b,f) JNJ7777120-treated SMG (c, g). SMG
of irradiated rats displaying damage in the epithelial architecture of the granular convoluted ducts, mild edema (red arrow), partial
loss of eosinophilic secretor granular material and vacuoles (arrow head). (d,h) SMG of JNJ7777120-treated and irradiated animals
showing preserved structure organization of secretor granules, with normal appearance of granular convoluted ducts with
eosinophilic secretion. (a–d) H&E staining. (e–h) PAS staining. (i) Occasional TUNEL-positive cells in glandular duct cells in
untreated and (j) JNJ777120-treated rats. (k) Massive presence of TUNEL-positive cells in ductal and acinar cells of glands of
irradiated rats. (l) Significant reduction of TUNEL-positive cells in glands of treated and irradiated rats. (m,n) Similar PCNA
immunoreactivity in SMG from untreated and JNJ7777120-treated rats. (o) Almost total absence of PCNA immunoreactivity in
irradiated gland. (p) Partial preservation of PCNA-positive cells in treated and irradiated glands. Arrows indicate positive cells.
Pictures were taken at 630x-fold magnification. Scale bar= 20 µm. (B) Average number of apoptotic cells and PCNA-positive cells
are shown. Error bars represent the means ± SEM. **P<0.01, ***P<0.001 vs. Untreated; # P<0.05, # # # P<0.001 vs. Untreated-5Gy.
doi: 10.1371/journal.pone.0069106.g003
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and quantity of saliva and tears [11,27], suggesting that H4R
may play some constitutive role in the maintenance of healthy
salivary epithelium and salivation. Also, comparable SMG
radioprotection was observed with histamine treatment (0.1
mg/kg) [3].
Whole-body radiation can cause severe damage to the
hematopoietic system, causing immediate cell death and
mitotic inhibition that lead to depopulation of bone marrow. As
a result, replenishment of peripheral blood does not take place,
leading to anemia and leucocytopenia, and therefore it is
necessary to identify a novel strategy for overcoming this injury
[1,2]. Results show that JNJ7777120 administration relieves
bone marrow aplasia and decreases occurrence of bone
marrow and peripheral blood micronucleated erythrocytes 3
days after radiation, indicating that JNJ7777120 administration
could reduce the genotoxic effect of total body irradiation in the
hematopoietic system. Also, JNJ7777120 markedly improves
the repopulation 30 days post-irradiation, accelerating
hematopoietic recovery.
Under pathological conditions, hematopoiesis may emigrate
from these bone marrow sites and may continue its cell
production much less efficiently, in other extramedullary sites,
such as spleen [1]. Administration of JNJ7777120 before
irradiation significantly prevents radiation-induced decrease in
wet weight and histopathological alterations in the spleen.
Our data obtained from in vivo experiments provide strong
evidence that JNJ7777120 efficiently protects normal tissues
against ionizing radiation-induced toxicity. JNJ777120 clearly
preserves the major histological parameters of the small
intestine and salivary gland, conserving intestinal crypts and
SMG functionality, while relieves radiation-induced
myelosupression and accelerates bone marrow recovery. The
reduction of radiation-induced apoptosis and genotoxic
damage are to be likely mechanisms for the radioprotective
activity of JNJ7777120.
In addition, radiation damage is to a large extent, caused by
the overproduction of ROS, which overwhelm the levels of
antioxidants, resulting in oxidative stress that not only damage
DNA but also cellular membranes, leading to lipid peroxidation
[28]. A significant increase in lipid peroxidation as measured by
TBARS, was observed 3 days after whole body irradiation in
spleen and small intestine while its level showed no significant
Figure 4.  Evidence of the radioprotective effect of JNJ7777120 on rat hematopoietic tissue 3 days after irradiation.  (A)
H&E stained representative bone marrow sections of (a) untreated-5Gy and (b) JNJ7777120-5Gy rats. Pictures were taken at 630x-
fold magnification. Scale bar= 20 µm. (B) Micronucleus frequency. ¶ The number of micronuclei (MN) was determined in 1,000
erythrocytes and is expressed as mean ± SEM. < The number of micronuclei (MN) was determined in 1,000 bone marrow cells and
is expressed as mean ± SEM (*P<0.05, **P<0.01, ***P<0.001 vs. Untreated; #P<0.05, # # #P<0.001 vs. Untreated-5Gy). (C) H&E
stained representative spleen sections of (a) untreated-5Gy and (b) JNJ7777120-5Gy rats. Pictures were taken at 630x-fold
magnification. Scale bar= 20 µm. (D) § Spleen’s percentage of body weight (spleen weights were divided by total body weight in
grams and multiplied by 100). Data represent the means ± SEM (*P<0.05 vs. Untreated).
doi: 10.1371/journal.pone.0069106.g004
Radioprotective Potential of JNJ7777120
PLOS ONE | www.plosone.org 9 July 2013 | Volume 8 | Issue 7 | e69106
variation in SMG. Administration of JNJ7777120 completely
reversed this oxidative damage induced by radiation in both
tissues, suggesting that it could protect cellular membrane from
radiation-induced lipid peroxidation. The radioprotective effect
of this compound was not associated with a modulation of total
cellular thiols. According to the data obtained, other potential
radioprotectors reduce oxidative damage [2], however further
studies are needed to fully characterized the antioxidant status
in whole body irradiated and JNJ7777120-treated rats.
In order to consider JNJ7777120 as a selective
radioprotector and therefore a clinically relevant agent able to
protect normal tissues without protecting tumoral cells, the
potential protection of tumor cells has to be evaluated. Present
findings demonstrate that JNJ7777120 was not able to
modulate significantly the radiosensitivity of two H4R
expressing human breast cancer cells [8,29], suggesting that it
does not interfere with the anti-tumor efficacy of radiation.
Moreover, this compound does not modulate growth of
melanoma and pancreatic carcinoma cell lines [30].
Hematopoietic tissue, small intestine and salivary glands
express H4R, which has become a major target of novel
therapeutics. The discovery of JNJ7777120 as the first orally
active, potent and selective non-imidazole H4R antagonist
allowed a significant advance in the understanding of the
Figure 5.  Effect of JNJ7777120 on bone marrow repopulation 30 days after whole body irradiation.  (A) Bone marrow
histopathology. (a,e) Normal trophism of untreated, and (b,f) JNJ7777120-treated bone marrow. (c,g) Bone marrow of irradiated rats
showing a reduced number of components and an important adipose replacement (red arrow head). (d,h) Bone marrow of treated
and irradiated animals demonstrating significant preservation of bone marrow components and minor adipose replacement. (a–d)
H&E staining. (e–h) PCNA immunoreactivity. Arrows indicate PCNA-positive cells. 630x-fold magnification. Scale bar= 20 µm. (B)
Histopathological characteristics of rat bone marrow. Error bars represent the means ± SEM (*P<0.05, **P<0.001 vs. Untreated; #
P<0.05 vs. Untreated-5Gy).
doi: 10.1371/journal.pone.0069106.g005
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pharmacology and function of H4R both in vitro and in vivo [10].
Paradoxically, histamine (0.1 mg/kg) treatment produces
similar radioprotective effects on small intestine, bone marrow
and SMG [3,5–7], suggesting that JNJ7777120 could exhibit
agonistic activity in this native biological system. These results
are consistent with recent evidence, which show that
JNJ7777120 cannot be considered the "standard" H4R
antagonist anymore, but depending on the parameter
assessed, JNJ7777120 may also act as agonist to human H4R.
It is noteworthy that, with respect to β-arrestin recruitment that
can occur independently of G protein activation, JNJ7777120
acts only as partial agonist, but with respect to ERK activation,
JNJ7777120 is actually a full agonist. Additionally, at mouse,
rat and dog H4R, histamine is a full agonist with respect to Gi
Figure 6.  Effect of JNJ7777120 on the radiobiological parameters of two human breast cancer cell lines.  (A) MDA-MB-231
and (B) MCF-7 cells were cultured in presence or absence of 10 µM JNJ7777120 and clonogenic survival was determined. (C)
Radiobiological parameters (SF 2Gy, Dose 0.01, Dose 0.10) were obtained from the survival curves adjusted to the linear quadratic
model [SF=e-(αD+βD2)]. Values are means ± SEM.
doi: 10.1371/journal.pone.0069106.g006
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activation in Sf9 insect cell membranes, whereas JNJ7777120
is a partial agonist at these H4R orthologs. These data indicate
that the H4R joins the growing family of 7 trans-membrane
receptors showing functional selectivity or biased signaling
[12,13]. Therefore, our results will also contribute to a better
understanding of the pathophysiological function of the H4R in
a native non-recombinant system.
In addition, it is important to highlight that side effects were
not observed in most important organs including bone marrow
and liver upon JNJ7777120 administration (data not shown).
In conclusion, these findings clearly confirm that
JNJ7777120 exhibits protective effects on the small intestine,
salivary glands and the hematopoietic system against whole-
body gamma-radiation. For that reason, JNJ7777120 is a
promising radioprotective agent with potential application in
radiation protection for cancer patients who receive
radiotherapy or radiosurgery.
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